U.S. markets open in 1 hour 19 minutes

Tenax Therapeutics, Inc. (TENX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.7500-0.0400 (-2.23%)
At close: 4:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
0
0
0
0
0
Operating Expense
30,952
9,868
8,555
6,893
9,206
Operating Income
-30,952
-9,868
-8,555
-6,893
-9,206
Net Non Operating Interest Income Expense
-2.24
-1.627
-
-
-
Other Income Expense
9.46
18.166
160.901
79.835
366.216
Pretax Income
-30,945
-9,851
-8,394
-6,813
-8,840
Tax Provision
-
-
-
-
0
Net Income Common Stockholders
-30,945
-9,851
-8,394
-14,144
-8,840
Diluted NI Available to Com Stockholders
-30,945
-9,851
-8,394
-14,144
-8,840
Basic EPS
-
-1.33
-1.35
-9.04
-6.27
Diluted EPS
-
-1.33
-1.35
-9.04
-6.27
Basic Average Shares
-
7,416
6,195
1,565
1,411
Diluted Average Shares
-
7,416
6,195
1,565
1,411
Total Operating Income as Reported
-30,952
-9,868
-8,555
-6,893
-9,206
Total Expenses
30,952
9,868
8,555
6,893
9,206
Net Income from Continuing & Discontinued Operation
-30,945
-9,851
-8,394
-6,813
-8,840
Normalized Income
-30,945
-9,851
-8,394
-6,813
-8,840
Interest Expense
2.24
1.627
-
-
-
Net Interest Income
-2.24
-1.627
-
-
-
EBIT
-30,943
-9,850
-8,555
-6,893
-9,206
EBITDA
-30,826
-
-
-
-
Reconciled Depreciation
117.017
114.748
107.279
9.016
13.621
Net Income from Continuing Operation Net Minority Interest
-30,945
-9,851
-8,394
-6,813
-8,840
Total Unusual Items Excluding Goodwill
-
-
-
-
0
Total Unusual Items
-
-
-
-
0
Normalized EBITDA
-30,826
-9,735
-8,448
-6,884
-9,192
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0